Literature DB >> 8290291

Kanamycin depletes cochlear polyamines in the developing rat.

C M Henley1.   

Abstract

Developing mammals are more sensitive to aminoglycoside antibiotics and other ototoxic agents than adults, with maximum sensitivity occurring during the period of anatomic and functional maturation of the cochlea. For the aminoglycoside antibiotics, the hypersensitive period in rats occurs during the second and third postnatal weeks. Toxicity is initially expressed as outer hair cell (OHC) damage in the high-frequency, basal region of the cochlea. Distortion-product otoacoustic emissions (DPOAEs), physiologic measures of OHC function, are particularly sensitive to aminoglycoside exposure during the period of rapid cochlear physiologic development. Toxicity is characterized by increased DPOAE thresholds and decreased amplitudes. The mechanism of developmental sensitivity to aminoglycosides is unknown. A potential biochemical target of aminoglycosides is the ornithine decarboxylase (ODC)-polyamine pathway. ODC activity is elevated in the developing rat cochlea, aminoglycosides inhibit cochlear ODC in developing rats, and alpha-difluoromethylornithine (a specific ODC inhibitor) impairs development of cochlear function. In the present study we demonstrate an incomplete polyamine response to aminoglycoside damage, characterized by inhibition of the polyamines spermidine and spermine and accumulation of putrescine in the organ of Corti. Aminoglycoside inhibition of polyamine synthesis may mediate developmental ototoxic hypersensitivity by interfering with developmental and repair processes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8290291     DOI: 10.1177/019459989411000112

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  1 in total

1.  Identification of ion-channel modulators that protect against aminoglycoside-induced hair cell death.

Authors:  Emma J Kenyon; Nerissa K Kirkwood; Siân R Kitcher; Molly O'Reilly; Marco Derudas; Daire M Cantillon; Richard J Goodyear; Abigail Secker; Sarah Baxendale; James C Bull; Simon J Waddell; Tanya T Whitfield; Simon E Ward; Corné J Kros; Guy P Richardson
Journal:  JCI Insight       Date:  2017-12-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.